Acclaimed actor Irrfan Khan, who has is back on the sets to shoot for "Angrezi Medium" after being diagnosed with neuroendocrine tumour, says he is taking baby steps to merge healing with work.
Irrfan released a statement addressing to his "friends in the media" and said the "last few months have been on a road to recovery a period to heal to fight the fatigue and face the reel and real world".
"I am aware of your concern and request to talk to you, share my journey, but I am fathoming it myself inhaling and internalising, taking baby steps to merge my healing with work and trying to experiment the amalgamation of both," he added.
The 52-year-old star says he is deeply touched by the wishes and prayers.
"I truly respect the way you respected my journey giving me time and space to heal. Thank you for your patience and the warmth and the love all through this overwhelming journey."
"I feel an urge to share with you something. I live my life in widening rings which spread over earth and sky. I may not ever complete the last one, but that is what I will try. I circle around God's primordial tower, and I circle ten thousand years long; And I still don't know if I'm a falcon, a storm, or an unfinished song - Rilke."
It was in March last year that the versatile actor had announced his diagnosis and said that he was going abroad for treatment. He returned to India in February this year.
"Angrezi Medium" is the sequel to the widely appreciated 2017 entertainer "Hindi Medium".
Produced by Dinesh Vijan and directed by Homi Adajania, the film also stars Deepak Dobriyal and Radhika Madan. According to reports, Kareena Kapoor Khan may also join the star cast.
Irrfan is currently shooting for the sequel in Udaipur.
--IANS
dc/pgh/
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
